Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001847903-22-000026
Filing Date
2022-05-02
Accepted
2022-05-02 16:30:25
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A cnta-20211231.htm   iXBRL 10-K/A 487204
2 EX-31.1 a20211231exhibit31110-ka.htm EX-31.1 5373
3 EX-31.2 a20211231exhibit312-10ka.htm EX-31.2 5802
  Complete submission text file 0001847903-22-000026.txt   851184

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20211231.xsd EX-101.SCH 3322
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20211231_def.xml EX-101.DEF 23513
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20211231_lab.xml EX-101.LAB 49953
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20211231_pre.xml EX-101.PRE 27106
10 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20211231_htm.xml XML 22686
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40445 | Film No.: 22882425
SIC: 2834 Pharmaceutical Preparations